214 related articles for article (PubMed ID: 34941572)
21. Oncogenic role of karyopherin α2 (KPNA2) in human tumors: A pan-cancer analysis.
Sun Y; Li W; Li X; Zheng H; Qiu Y; Yang H
Comput Biol Med; 2021 Dec; 139():104955. PubMed ID: 34735944
[TBL] [Abstract][Full Text] [Related]
22. Zinc finger C3H1-type containing serves as a novel prognostic biomarker in human pan-cancer.
Liang W; Chen W; Wei J; Yao H; Shi J; Hou X; Deng Y; Ou M
Gene; 2022 Apr; 820():146251. PubMed ID: 35131366
[TBL] [Abstract][Full Text] [Related]
23. A Pancancer Analysis of the Oncogenic Role of S100 Calcium Binding Protein A7 (S100A7) in Human Tumors.
Peng G; Tsukamoto S; Okumura K; Ogawa H; Ikeda S; Niyonsaba F
Biology (Basel); 2022 Feb; 11(2):. PubMed ID: 35205150
[TBL] [Abstract][Full Text] [Related]
24. Pan-Cancer Analysis of the Oncogenic and Immunological Role of
Ding J; Meng Y; Han Z; Luo X; Guo X; Li Y; Liu S; Zhuang K
Front Oncol; 2022; 12():811567. PubMed ID: 35651805
[TBL] [Abstract][Full Text] [Related]
25. A systematic pan-cancer analysis identifies RIOK3 as an immunological and prognostic biomarker.
Li J; Sun R; He L; Sui G; Di W; Yu J; Su W; Pan Z; Zhang Y; Zhang J; Ren F
Am J Transl Res; 2022; 14(6):3750-3768. PubMed ID: 35836879
[TBL] [Abstract][Full Text] [Related]
26. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
Front Immunol; 2021; 12():646523. PubMed ID: 33679809
[TBL] [Abstract][Full Text] [Related]
27. Eight novel MSH6 germline mutations in patients with familial and nonfamilial colorectal cancer selected by loss of protein expression in tumor tissue.
Plaschke J; Krüger S; Dietmaier W; Gebert J; Sutter C; Mangold E; Pagenstecher C; Holinski-Feder E; Schulmann K; Möslein G; Rüschoff J; Engel C; Evans G; Schackert HK;
Hum Mutat; 2004 Mar; 23(3):285. PubMed ID: 14974087
[TBL] [Abstract][Full Text] [Related]
28. A systematic pan-cancer study demonstrates the oncogenic function of heterogeneous nuclear ribonucleoprotein C.
Pan C; Wu Q; Feng N
Aging (Albany NY); 2022 Mar; 14(6):2880-2901. PubMed ID: 35344508
[TBL] [Abstract][Full Text] [Related]
29. Mismatch repair genes expression defects & association with clinicopathological characteristics in colorectal carcinoma.
Kaur G; Masoud A; Raihan N; Radzi M; Khamizar W; Kam LS
Indian J Med Res; 2011 Aug; 134(2):186-92. PubMed ID: 21911971
[TBL] [Abstract][Full Text] [Related]
30. Mismatch repair pathway: molecules, functions, and role in colorectal carcinogenesis.
Sameer AS; Nissar S; Fatima K
Eur J Cancer Prev; 2014 Jul; 23(4):246-57. PubMed ID: 24614649
[TBL] [Abstract][Full Text] [Related]
31. Biochemical analysis of the human mismatch repair proteins hMutSα MSH2(G674A)-MSH6 and MSH2-MSH6(T1219D).
Geng H; Sakato M; DeRocco V; Yamane K; Du C; Erie DA; Hingorani M; Hsieh P
J Biol Chem; 2012 Mar; 287(13):9777-9791. PubMed ID: 22277660
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive analysis of pan-cancer reveals the potential of SLC16A1 as a prognostic and immunological biomarker.
Chen L; Li Y; Deng X
Medicine (Baltimore); 2023 Mar; 102(11):e33242. PubMed ID: 36930112
[TBL] [Abstract][Full Text] [Related]
33. Application of stopped-flow kinetics methods to investigate the mechanism of action of a DNA repair protein.
Biro FN; Zhai J; Doucette CW; Hingorani MM
J Vis Exp; 2010 Mar; (37):. PubMed ID: 20357752
[TBL] [Abstract][Full Text] [Related]
34. Synchronous breast cancers with different morphologic and molecular phenotypes occurring in Lynch syndrome: what does the heterogeneity imply?
D'Arcy C; Wen YH; Stadler ZK; Brogi E; Shia J
Am J Surg Pathol; 2011 Nov; 35(11):1743-8. PubMed ID: 21997695
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant therapy induces loss of MSH6 expression in colorectal carcinoma.
Bao F; Panarelli NC; Rennert H; Sherr DL; Yantiss RK
Am J Surg Pathol; 2010 Dec; 34(12):1798-804. PubMed ID: 21107085
[TBL] [Abstract][Full Text] [Related]
36. Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parameters.
Hashmi AA; Ali R; Hussain ZF; Faridi N; Khan EY; Bakar SMA; Edhi MM; Khan M
World J Surg Oncol; 2017 Jun; 15(1):116. PubMed ID: 28651545
[TBL] [Abstract][Full Text] [Related]
37. Pan-Cancer Analysis of Voltage-Dependent Anion Channel (VDAC1) as a Cancer Therapeutic Target or Diagnostic Biomarker.
Wang Z; Cheng Y; Song Z; Zhao R
Dis Markers; 2022; 2022():5946110. PubMed ID: 35958281
[TBL] [Abstract][Full Text] [Related]
38. Pan-cancer analysis of the oncogenic role of discs large homolog associated protein 5 (DLGAP5) in human tumors.
Tang N; Dou X; You X; Shi Q; Ke M; Liu G
Cancer Cell Int; 2021 Aug; 21(1):457. PubMed ID: 34454476
[TBL] [Abstract][Full Text] [Related]
39. The distinct spectra of tumor-associated Apc mutations in mismatch repair-deficient Apc1638N mice define the roles of MSH3 and MSH6 in DNA repair and intestinal tumorigenesis.
Kuraguchi M; Yang K; Wong E; Avdievich E; Fan K; Kolodner RD; Lipkin M; Brown AM; Kucherlapati R; Edelmann W
Cancer Res; 2001 Nov; 61(21):7934-42. PubMed ID: 11691815
[TBL] [Abstract][Full Text] [Related]
40. Role of the mismatch repair gene, Msh6, in suppressing genome instability and radiation-induced mutations.
Barrera-Oro J; Liu TY; Gorden E; Kucherlapati R; Shao C; Tischfield JA
Mutat Res; 2008 Jul; 642(1-2):74-9. PubMed ID: 18538799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
